ASX:IIQ

INOVIQ (IIQ) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
15.56%
Price Target
N/A

About INOVIQ

INOVIQ Ltd engages in the research, development, and commercialization of diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. The company offers hTERT test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET for capturing and isolating exosomes from liquid biopsy sample. Its cancer diagnostic pipeline includes blood tests in development for ovarian, breast, and other cancers. The company was formerly known as BARD1 Life Sciences Limited and changed its name to INOVIQ Ltd in December 2021. INOVIQ Ltd was incorporated in 1983 and is headquartered in Notting Hill, Australia.

IIQ Stock News Headlines

IIQ.AX - INOVIQ Ltd
Exposed: 10 CENT Crypto to Explode April 20th?
The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…
See More Headlines
Receive IIQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for INOVIQ and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
15
Year Founded
N/A

Profitability

Net Income
$-6,510,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.58 million
Book Value
A$0.18 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
2.20
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Dr. Leearne Maree Hinch B.Sc.
    B.V.M.S., BSc., M.B.A., M.R.C.V.S., Chief Executive Officer
  • Mr. Mark Edwards BAcc
    C.A., CA, CFO & Company Secretary
  • Prof. Gregory Edward Rice BSc (Hons)
    GradDipMgt, MHA, Ph.D., Chief Scientific Officer

This page (ASX:IIQ) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners